Adaptive Biotechnologies Corporation (ADPT) Financial Statements (2024 and earlier)

Company Profile

Business Address 1165 EASTLAKE AVE E
SEATTLE, WA 98109
State of Incorp. WA
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments498,196353,061688,269576,866
Cash and cash equivalents90,030139,065123,43696,576
Short-term investments408,166213,996564,833480,290
Receivables40,05717,60910,94715,076
Inventory, net of allowances, customer advances and progress billings14,45319,26314,0639,069
Inventory14,45319,26314,0639,069
Other undisclosed current assets9,44012,81513,63511,679
Total current assets:562,146402,748726,914612,690
Noncurrent Assets
Operating lease, right-of-use asset80,76387,67899,350 
Property, plant and equipment83,44785,26239,69260,355
Long-term investments and receivables  217,145118,525105,435
Long-term investments  217,145118,525105,435
Intangible assets, net (including goodwill)125,799127,498129,197130,900
Goodwill118,972118,972118,972118,972
Intangible assets, net (excluding goodwill)6,8278,52610,22511,928
Restricted cash and investments2,3982,1382,1382,138
Other noncurrent assets2,064875598784
Total noncurrent assets:294,471520,596389,500299,612
TOTAL ASSETS:856,617923,3441,116,414912,302
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,50828,29228,34916,948
Employee-related liabilities15,64211,9508,124
Accounts payable8,0843,3073,2374,453
Accrued liabilities12,4249,34313,1624,371
Deferred revenue64,11580,46073,31960,994
Debt    
Deferred rent credit    371
Other undisclosed current liabilities25,1655,0553,529 
Total current liabilities:109,788113,807105,19778,313
Noncurrent Liabilities
Long-term debt and lease obligation 106,685104,33336,607
Long-term debt, excluding current maturities    
Finance lease, liability    36,607
Liabilities, other than long-term debt157,37198,750163,618226,343
Deferred revenue58,59998,750163,618219,332
Deferred rent credit    6,918
Other liabilities    93
Operating lease, liability98,772106,685104,333 
Other undisclosed noncurrent liabilities 125,360   
Total noncurrent liabilities:282,731205,435267,951262,950
Total liabilities:392,519319,242373,148341,263
Equity
Equity, attributable to parent464,165603,992743,266571,039
Common stock14141412
Additional paid in capital1,387,3491,324,0061,253,971935,834
Accumulated other comprehensive income (loss)(4,116)(1,137)893671
Accumulated deficit(919,082)(718,891)(511,612)(365,478)
Equity, attributable to noncontrolling interest(67)110  
Total equity:464,098604,102743,266571,039
TOTAL LIABILITIES AND EQUITY:856,617923,3441,116,414912,302

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues185,308154,34498,38285,071
Cost of revenue
(Cost of Goods and Services Sold)
(57,909)(49,301)(22,530)(22,274)
Gross profit:127,399105,04375,85262,797
Operating expenses(327,585)(314,009)(228,669)(141,188)
Operating loss:(200,186)(208,966)(152,817)(78,391)
Interest and debt expense(4,238)   
Loss from continuing operations before equity method investments, income taxes:(204,424)(208,966)(152,817)(78,391)
Other undisclosed income from continuing operations before income taxes4,0561,668  
Loss from continuing operations before income taxes:(200,368)(207,298)(152,817)(78,391)
Income tax expense    (2,100)
Loss from continuing operations:(200,368)(207,298)(152,817)(80,491)
Loss before gain (loss) on sale of properties:(207,298)(152,817)(80,491)
Other undisclosed net income  6,59011,885
Net loss:(200,368)(207,298)(146,227)(68,606)
Net income attributable to noncontrolling interest17719  
Net loss attributable to parent:(200,191)(207,279)(146,227)(68,606)
Preferred stock dividends and other adjustments    (964)
Net loss available to common stockholders, diluted:(200,191)(207,279)(146,227)(69,570)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(200,368)(207,298)(146,227)(68,606)
Other undisclosed comprehensive income (loss)(2,979)(2,030)  
Comprehensive loss:(203,347)(209,328)(146,227)(68,606)
Comprehensive income, net of tax, attributable to noncontrolling interest17719  
Other undisclosed comprehensive income, net of tax, attributable to parent   222778
Comprehensive loss, net of tax, attributable to parent:(203,170)(209,309)(146,005)(67,828)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: